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PURPOSE. Bone marrow-derived cells have been shown to play roles in angiogenesis.  
Although these cells have been shown to promote angiogenesis, it is not yet clear 
whether these cells affect all types of angiogenesis. This study investigated the 
involvement of bone marrow-derived cells in pathological and physiological 
angiogenesis in the murine retina. 
MATERIALS AND METHODS. The oxygen-induced retinopathy (OIR) model was used as 
a retinal angiogenesis model in newborn mice. To block the influence of bone marrow-
derived cells, the mice were irradiated with a 4-Gy dose of radiation from a 
137
Cs 
source.  Irradiation was performed in four different conditions with radio dense 2-cm 
thick lead disks ; (1) H group, the head were covered with these discs to protect the eyes 
from radiation; (2) A group, all of the body was covered with these discs; (3) N group, 
mice were completely unshielded; (4) C group, mice were put in the irradiator but were 
not irradiated. On P17, the retinal areas showing pathological and physiological retinal 
angiogenesis were measured and compared to the retinas of non-irradiated mice.  
RESULTS. Although irradiation induced leukocyte depletion, it did not affect the number 
of other cell types or body weight. Retinal nonperfusion areas were significantly larger 
in irradiated mice than in control mice (P<0.05), indicating that physiological 
angiogenesis was impaired. However, the formation of tuft-like angiogenesis processes 
was more prominent in the irradiated mice (P<0.05), indicating that pathological 
angiogenesis was intact. 
CONCLUSIONS. Bone marrow-derived cells seem to be differentially involved in the 
formation of physiological and pathological retinal vessels. Pathological angiogenesis in 
the murine retina does not require functional bone marrow-derived cells, but these cells 
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are important for the formation of physiological vessels. Our results add a new insight 
into the pathology of retinal angiogenesis and bolster the hypothesis that bone marrow 
cells are involved in the pathology or severity of retinal angiogenic diseases.  
 
Key words 




Angiogenesis is associated with retinal diseases such as diabetic retinopathy, 
retinopathy of prematurity and retinal vein occlusion. The common underlying 
pathological condition of those diseases is retinal hypoxia caused by a loss of functional 
vessels. The hypoxic retina releases angiogenic cytokines that are key players in retinal 
angiogenesis. Among these factors, vascular endothelial growth factor (VEGF) is key,[1, 
2] and the efficacy of an anti-VEGF strategy has been demonstrated in clinical practice. 
 Although it is clear that cytokines play a central role in angiogenesis, it is also 
becoming evident that the mechanism of angiogenesis is more complicated than 
previously thought and that there are many factors involved in the process. In particular, 
the involvement of bone marrow (BM)-derived stem and progenitor cells has become a 
new paradigm in the mechanism of angiogenesis. Initially, the effect of BM-derived 
cells was reported to be mediated mainly by their differentiation into pericyte/smooth 
muscle cells [3-6] and/or endothelial cells [7, 8] that were incorporated into the walls of 
new vessels. Later studies suggested an alternative pathway in which the stem cells 
contributed to the neovascular process by their paracrine effects [9, 10]. In fact, a 
variety of cytokines are released by stem cells in vitro, including MCP-1, VEGF-A, 
FGF-2, and IL-6. [10] All of these cytokines have been shown to have positive effects 
on promoting new vessel formation [10]. 
 Angiogenesis can be physiological or pathological [11]. Physiological 
angiogenesis is exemplified by neovascularization in embryogenesis: In this process, 
physiological blood vessels are formed. In contrast, pathological angiogenesis is 
associated with disease conditions such as cancer, age-related macular degeneration, 
retinopathy of prematurity, and diabetic retinopathy: In these diseases, non-
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physiological vasculature develops. In terms of the retina, pathological angiogenesis is 
the major pathogenesis that causes functional impairment. Although there are some 
overlaps between the two types of angiogenesis, the underlying mechanisms have 
marked differences [11].  
 In the retina, the two kinds of angiogenesis can be distinguished by the location 
of the new blood vessels: Intraretinal angiogenesis is seen mostly in physiological 
angiogenesis during development, while extraretinal angiogenesis occurs on the surface 
of the retina. The latter is a type of pathological angiogenesis that causes severe vision 
loss in many ischemic retinal diseases. Although little is known about the mechanistic 
differences between intra- and extraretinal angiogenesis, induction of intraretinal 
angiogenesis rather than extraretinal angiogenesis in the ischemic retina has potential as 
a therapeutic strategy. 
 In the present study, we investigated whether BM-derived cells have different 
roles in intra- and extraretinal angiogenesis using the murine oxygen-induced 
retinopathy (OIR) model. The OIR mouse model is a hypoxia-induced retinal 
neovascularization model in which intraretinal and extraretinal angiogenesis develop 
simultaneously [12].  
          
Materials and Methods 
The oxygen-induced retinopathy (OIR) model  
Mice were treated according to the regulations put forth in the ARVO “Statement for 
the Use of Animals in Ophthalmic and Vision Research” and the “Guidelines for 
Animal Experimentation” at Kyoto University. All animals were obtained from Japan 
SLC (Shizuoka, Japan) and housed in the Institute of Laboratory Animals at the 
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Graduate School of Medicine of Kyoto University. OIR was induced in newborn 
C57BL/6 mice as described by Smith et al. [13] Briefly, on postnatal day 7 (P7), 
newborn mice were placed along with their dams into a 75% oxygen environment (Fig. 
1). On P12, after 5 days in this environment, mice were transferred back to a normal 
laboratory environment (room air). During this period, the room temperature was 
maintained at 20 C, and illumination was provided by standard fluorescent lighting on a 
12-hour light-dark cycle. Pups were nursed by their dams, and dams were given food 




Immediately after their return to room air on day P12, mice were irradiated with a 
Gammacell 40 Exactor (Nordion, Ottawa, Canada) to impair the function of BM cells 
(Fig. 1A). As shown in Figure 1B, irradiation was performed using radiodense 2-cm 
thick lead disks to protect the head (H) or entire body (all-covered, A) of mice; 
alternatively, mice were completely unshielded (noncovered, N). The control group (C) 
mice were put in the irradiator but were not irradiated.  
 Five different doses of radiation, ranging from 2 to 6.5 Gy, were tested to 
identify a dose that would affect leukocyte levels but not erythrocyte levels. Mice were 
irradiated on day P12, and hematological examination was performed on P17 (Erma 
Particle Counter PCE 170, Erma Inc, Tokyo, Japan). The mice were weighed 1, 3, and 5 
days after irradiation to determine the effect of radiation, if any, on general 
development. 
 
Bone marrow transplantation in OIR model 
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Lethal irradiation (7.5 Gy) was performed to the recipient mice (P12). Bone marrow is 
obtained by slowly flushing medium (RPMI 1640 culture medium containing 2.5% 
HEPES (1M) and 1% gentamicin) inside the diaphyseal channel of femur and tibia of 
the donor mice (C57BL/6-Tg CAG-EGFP, SLC Inc., Shizuoka, Japan) with a syringe 
through a 27-gauge needle. The cells were injected to the irradiated recipient mice 
intraperitoneally (200μL/mouse). The retinas of recipient mice were examined at P26. 
 
Retinal whole-mount preparation and immunohistochemistry 
Retinal whole-mounts were prepared as described previously [14]. Briefly, mouse 
retinas were harvested and fixed with 4% paraformaldehyde and methanol, then blocked 
using 50% fetal bovine serum/20% normal goat serum for 1 hour at room temperature 
before exposure to antibodies. The following primary antibodies were used: anti-CD31 
(BD Biosciences Pharmingen, San Diego, CA) to stain vascular endothelial cell, anti-
collagen type IV (Chemicon, Temecula, CA) to stain vascular collagen IV, and anti-
GFAP (Dako, Tokyo Japan) for astrocyte staining. The secondary antibodies were 
Alexa 488- or 594-conjugated antibodies (Invitrogen, Eugene, OR).  
 
Imaging and quantifying the areas of nonperfusion and neovascular tufts  
Images of the retina were obtained with a Microscope Axio Imager (Carl Zeiss, Jena, 
Germany), and quantification was performed using Axiovision version 4.3 software 
(Carl Zeiss). Whole retinal montages were created by the software based on defined 
landmarks such as the optic disc and major vessels. Quantification of areas of 
nonperfusion and neovascular tufts was performed on these montages as described 
previously [15]. In short, areas of nonperfusion and neovascular tufts were selected 
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using Photoshop (Adobe, Tokyo, Japan) and high-resolution images of immunostained 
retinal whole mounts (Fig. 3G and 3H). The total areas were expressed in pixels that 
were then converted to square micrometers. The conversion factor was calculated to be 
32.17μm2/pixel for our set-up. 
 
Statistical analysis 
All results were presented as the mean ± SD unless otherwise noted. Statistical analysis 
was performed using SPSS statistical software. Data were compared between groups 
using one-way ANOVA followed by the Bonferroni test or unpaired t-test as 
appropriate. The P value <0.05 was considered statistically significant. 
 
Results 
Effect of 4-Gy irradiation on murine development and hematological cell count 
Five different doses of radiation were tested to identify an optimal radiation dose that 
would reduce leukocyte levels but not erythrocyte levels. We found that a 4-Gy dose 
delivered using a 1.11 Gy/minute dose rate significantly impaired the leukocyte number 
but not the erythrocyte number. A dose greater than 5 Gy significantly reduced both 
leukocytes and erythrocytes. At a 4-Gy irradiation dose, the hemoglobin concentration 
was not affected significantly (Fig. 2A). The mean weight of mice exposed to 4-Gy 
radiation was not reduced compared to control animals on days 1 (P13), 3 (P15), or 5
 
(P17) after radiation (Fig. 2B). We concluded that a 4-Gy dose of radiation did not 
delay the normal development of these animals, at least during the experimental period. 
 The 4-Gy dose of irradiation on P12 did not significantly change either the 




/micro L, RBC: 5.9 ± 0.2 x10
6
/micro L) compared to the C group (WBC: 2.4 ± 0.8 
x10
3
/micro L, RBC: 6.4 ± 0.5 x10
6
/micro L) (Fig. 2C). In contrast, 4-Gy irradiation to 
the body (H group) significantly reduced the leukocyte count to 0.7 ± 0.3 x103/micro L; 
the erythrocyte count and hemoglobin concentration did not differ significantly in the H 
group compared to the C and A groups.  In addition, the 4-Gy dose irradiation 
eliminated the colony forming unit (CFU-Hill) in the peripheral blood.                                                 
 
Definition of physiological and pathological angiogenesis in the OIR model 
Retinal whole mounts were analyzed for OIR on P17 (n=9). Exposure to high levels of 
oxygen causes marked retinal capillary inhibition, especially in the central area (Fig. 
3A). After the mice were transferred back to a normal environment (i.e. to room air), 
new vessels grew from the superficial plexus at the transition between the perfusion and 
nonperfusion areas; the vessels extended to the central avascular areas. As shown in 
Figure 3B and 3C, physiological (intraretinal) angiogenesis was observed as extending 
filopodias that colocalized with the underlying astrocytic processes. In addition, 
numerous neovascular tufts were observed in the mid-peripheral region of the retinas 
(Fig. 3B and 3E). Unlike physiological angiogenesis, which extended to the central 
avascular areas, the tufts were not associated with astrocytes (Fig. 3F) and were highly 
abnormal in appearance, consisting of swirls of capillaries folded in close proximity to 
each other and breaking through the inner limitans to the vitreous cavity. This type of 
angiogenesis is typical of pathological angiogenesis in the OIR model.  
 
Leukocyte depletion affects physiological angiogenesis but not pathological 
angiogenesis 
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In the OIR model, the nonperfusion areas were largest on P12 in control mice (4301.0 ± 
505.9 mm
2
) and gradually decreased as physiological angiogenesis progressed 
(described above). The avascular areas, which represent physiological angiogenesis, and 
the areas with tufts, which represent pathological angiogenesis, were measured on P17 
and compared (Fig. 4A-D). 
 There was no significant difference in the size of the avascular areas in A group 
mice and control mice (C: 1990 ± 570.47, A: 2190 ± 389.89 mm2, P<0.05; Fig. 4E). 
In addition, the areas with neovascular tufts in the A group were not significantly 
different than controls (C: 385 ± 64.38, A: 416 ± 70.78 mm2; Fig. 4F). 
 In contrast, in group H, the 4-Gy dose of irradiation significantly increased both 
the mean area of nonperfusion (to 2660.0 ± 349 mm
2
, P<0.05) and the mean area of 
neovascular tufts (to 500.0 ± 96.8 mm
2
, P<0.05). In addition, in group N, the mean 
avascular area and neovascular area were larger than that of the other groups (data not 
shown); however, we could not exclude the possibility that irradiation directly affected 
retinal angiogenesis.  
 
Bone marrow derived cells migrate into the avascular areas in OIR model 
To investigate whether bone marrow derived cells participate in the neovascularization 
of OIR model, bone marrow transplantation was performed with GFP+ bone marrow on 
P12,when the mice were transferred back to a normal laboratory environment (room air) 
after 5 days in 75% O2 environment. The retina was examined at P26. Bone marrow 
derived cells (green) were observed especially in avascular area of the retina where 
physiological angiogenesis will develop and only a small number of cells were observed 




In the present study, we showed that depletion of BM-derived cells in the OIR model, 
including leukocytes and BM-derived stem cells, leads to an increase in the retinal 
avascular area and in neovascular tufts. In addition, we found that bone marrow derived 
cells seem to be mobilized more in the avascular area than the neovascular tufts in the 
model. These results suggest that physiological intraretinal angiogenesis is controlled by 
BM-derived stem cells, and that pathological extraretinal angiogenesis is not affected 
fully by these cells. 
 Irradiation to just part of the body, excluding the head, also affected the 
formation of physiological and pathologic angiogenesis in the mouse OIR model. The 
all-covered A group had almost the same mean avascular and neovascular area as the 
non-irradiated C group, indicating that the lead cover effectively shielded the mice from 
radiation. In contrast, the head-covered H group had significantly larger avascular and 
neovascular areas compared to the non-irradiated control (C) mice. These data showed 
that the decreased physiological angiogenesis and increased pathological angiogenesis 
was primarily the result of irradiation to the body rather than to the eye. 
 Considering that these changes were observed very early after irradiation, the 
depletion of BM-derived cells is the most likely cause of the decreased vascular 
formation. Although damage to the esophagus, gastrointestinal tract, and urinary organs 
can also occur right after irradiation, the development of the mice was almost normal, 
indicating that the damage to these systems had a minimal impact in the present study. 
Among the BM-derived cells, the WBC population seemed to contain the cells 
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responsible for the observed effects because the number of RBCs was not significantly 
decreased even in whole-body irradiated mice. 
 Among the WBCs, circulating hematopoietic stem cells (HSCs) are good 
candidates for being responsible for the differences we observed in vascular formation 
in the present study. The cells are derived from bone marrow [16] and have been shown 
to participate in normal and pathological postnatal angiogenesis [17]. HSCs circulate 
and contribute to angiogenesis/vasculogenesis, as demonstrated in experimental models 
of myocardial infarction [18] and hind limb [19], corneal [5], and choroid development 
[6, 20]. Several clinical studies have reported the efficacy of BM-derived cells in 
promoting angiogenesis in ischemic diseases [21-23]. Although BM-derived stem cells 
are considered a potential therapy with a strong angiogenic effect, their exact role in 
promoting angiogenesis is still unclear. BM-derived stem cells differentiate into mature 
endothelial cells, perivascular cells, and into other cell types that control angiogenesis 
directly or indirectly. It has even been suggested that BM-derived cells work as an anti-
angiogenic agent in some circumstances. 
BM-derived cells may be involved both directly and indirectly in retinal and 
choroidal angiogenesis. Ritter et al. reported that BM-derived cells administered 
intravitreally promote physiological retinal angiogenesis [24]. Intravitreal injection of 
BM-derived progenitor cells promoted revascularization of nonperfusion area and 
reduced neovascular tuft formation in the OIR model. They hypothesized that 
neovascular tuft formation was reduced following physiological revascularization or 
that the injected BM cells acted as immune suppressive agents and reduced the output 
of tuft-inducing angiogenic factors. Ishida et al. reported that leukocytes adhere to 
vasculature and prune immature vessels via Fas-FasL-mediated selective apoptosis 
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during development [25]. Taken together, these data suggest that BM-derived cells may 
have roles both in new vessel formation and in excessive vessel pruning in the retina.  
Similarly, the role of BM-derived cells in choroidal neovascularization (CNV) 
remains unclear. BM-derived cells can participate in the formation of CNV;
2
 however, it 
is difficult to determine the effect of those cells in CNV formation because the cells 
might differentiate into many different cell types [26]. We have suggested that BM-
derived cells may act as CNV suppressors after investigating circulating BM-derived 
cells both in age-related macular degeneration (AMD) patient [27] and in vitro 
(presented at ARVO 2008). 
Considering earlier data, it is possible that BM-derived cells might have a 
biphasic effect in angiogenesis that can be changed by environmental factors and 
angiogenesis conditions. In the present study, we developed a unique method to 
suppress BM-derived cells. Our results suggest that the development of physiological 
vessels and abnormal neovascular might be controlled by different mechanisms in the 
retina. Considering that neovascular tuft formation occurred after almost complete loss 
of leukocytes, most likely including BM-derived progenitor cells, the formation of 
pathological angiogenesis that is observed in diabetic retinopathy and retinopathy of 
prematurity might be independent of BM-derived cells. Of course, this result does not 
exclude the involvement of BM-derived cells in pathological angiogenesis, but it 
indicates that the involvement is not as strong as the involvement of BM-derived cells 
in physiological angiogenesis of the retina. The function of BM-derived stem cells has 
been reported to reduce markedly with age and with diseases such as diabetes. The 
results of this study explain the enlargement of the avascular area along with the 
development of extraretinal neovascularization that is observed in patients with 
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advanced diabetes. We are currently investigating the correlation between the status of 
diabetic retinopathy and the function of BM-derived cells. 
There were limitations to this study. First, we did not identify the particular cell 
types responsible for our observations. Although we confirmed that CFU-Hill was 
reduced in the peripheral blood of irradiated mice (data not shown), our method could 
not distinguish those cells from the leukocyte population. Second, irradiation is not a 
physiological condition, and this must be kept in mind when interpreting the 
implications of our results for actual disease states. 
 
Conclusion 
In conclusion, our results suggest that BM-derived cells are differentially 
involved in physiological angiogenesis and pathological angiogenesis in the mouse 
retina. This raises the possibility that pathological angiogenesis, a key change in many 
ischemic, vision-threatening retinal diseases, increases when BM-derived cells lose their 
function. Although further studies are needed to confirm this finding, our results 
provide new insights into the pathology of retinal neovascular diseases.  
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FIGURE 1. The oxygen-induced retinopathy mouse model used in the study. (A) The 
time course for experimental animals. P7 mice were exposed to a 75% oxygen 
atmosphere for five days, irradiated, and moved to normal (room) air until examination 
on P17. (B) Lead plates were used to shield none, N, the head, H, or all, A, of each 
mouse from radiation.  
 
FIGURE 2. Mouse blood cell counts, hemoglobin levels, and body weight. (A) Mice 
irradiated with the indicated dose of radiation. 2 Gy and 4 Gy doses of irradiation 
effectively depleted leukocytes without affecting erythrocytes or hemoglobin levels. 
(n=3) (B) Relative body weight change of irradiated mice to the average weight of P13 
control mice on the indicated post-natal day according to lead cover. There were no 
differences in body weight among the groups. (n=4) (C) Blood cell counts and 
hemoglobin levels in mice according to lead cover. Control, C (n=9), covering the entire 
body, A (n=7), protected mice from leukocyte depletion, but covering only the head, H 
(n=5), and no cover at all, N (n=5), induced leukocyte depletion. WBC: white blood 
cells; RBC: red blood cells; Hb: hemoglobin. 
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FIGURE 3. Oxygen-induced retinopathy. (A) Representative image of a flat-mount of 
the retina of a P12 control mouse. Note that the central area of the retina is avascular. 
(B) Representative image of a flat-mount of the retina of a P17 control mouse. The 
avascular area is decreased in size relative to that seen in a retina from a P12 mouse; 
physiological and tuft-like pathological neovascularization can also be seen. (C-F) 
Representative images of neovascularization sites in control (higher magnification). (C 
and D) Intraretinal physiological angiogenesis and (E and F) extraretinal pathologic 
angiogenesis is visible. Note the differences in the angiogenesis patterns and in 
astrocyte involvement. (G and H) Representative images showing how avascular and 
neovascular areas were calculated. The yellow shading represents neovascular tufts and 
white shading represents avascular area. Each area was defined and measured using 
image processing software. Red: CD31 immunofluorescence. Red signal: Panels A-C 
and E, collagen IV; panel F, GFAP; panel G and H, CD31. Green signal (all panels): 
CD31. Magnification, x10 (A, and B), x40 (C, D, E, and F), x4 (G and H).  
 
FIGURE 4. Representative images of avascular and neovascular areas of retinas from 
mice in each experimental group. (A) P12 mouse; (B) control (non-irradiated) P17 
mouse; (C) completely shielded P17 mouse; (D): head-shielded P17 mouse. Compared 
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to retinas from mice in the control or the completely shielded groups, retinas from head-
shielded P17 mice had larger avascular and neovascular areas. (E) Quantitation of the 
avascular areas in each group. The head-shielded group (H, n=10) had an average 
avascular area that was significantly larger (P<0.05) than in the other groups (Control, 
C (n=9), covering the entire body, A (n=6)). (F) Quantitation of the neovascular areas in 
each group. Neovascularization was not observed at P12. At P17, the head-shielded 
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